Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg-Reference-Cited by-同舟云学术

Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg

Published:2012-12 Issue:2 Volume:57 Page:217-223
ISSN:1896-1126
Container-title:Advances in Medical Sciences
language:en
Short-container-title:Advances in Medical Sciences

Author:

Szałek E,Tomczak H,Kamińska A,Grabowski T,Smuszkiewicz P,Matysiak K,Wolc A,Kaczmarek Z,Grześkowiak E

Publisher

Elsevier BV

Subject

General Medicine

Link

http://versita.metapress.com/index/C2563313K8R30M27.pdf

Reference41 articles.

1. Farmakokinetyczno-farmakodynamiczne zasady stosowania antybiotyków u chorych leczonych z powodu sepsy [Pharmacokinetic and pharmacodynamic considerations of antimicrobial therapy in sepsis];Smuszkiewicz;Anest Intens Ter.,2007

2. Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens;Scaglione;Int J Antimicrob Agents.,2008

3. Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group;Lipman;Antimicrob Agents Chemother,1998

4. Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis;Gous;Int J Antimicrob Agents.,2005

5. An updated review of its pharmacology, therapeutic efficacy and tolerability;Davis;Drugs.,1996

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock — rationale and design of a multicenter randomized controlled superiority trial;Trials;2019-12

2. Influence of antibiotic treatment on the detection of S. aureus in whole blood following pathogen enrichment;BMC Microbiology;2019-08-06

3. Pharmacokinetic and Pharmacodynamic Considerations of Antibiotics of Last Resort in Treating Gram-Negative Infections in Adult Critically Ill Patients;Current Infectious Disease Reports;2018-04-05

4. Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art;Expert Review of Anti-infective Therapy;2017-08-18

5. Acute Kidney Injury and Renal Replacement Therapy;Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill;2017-06-20